Granite Investment Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Granite Investment Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,265	Closed	-$603K	–	362
2019 Q3	$603K	Hold	36,265	–	–	0.03%	255
2019 Q2	$499K	Sell	36,265 -31,836	-47%	-$487K	0.03%	275
2019 Q1	$1.17M	Buy	+68,101	New	+$1.08M	0.07%	192
2016 Q1	–	Sell	-85,532	Closed	-$984K	–	317
2015 Q4	$984K	Sell	85,532 -14,663	-15%	-$181K	0.09%	227
2015 Q3	$1.35M	Buy	100,195 +29,119	+41%	+$395K	0.13%	172
2015 Q2	$985K	Buy	71,076 +9,130	+15%	+$123K	0.09%	213
2015 Q1	$872K	Buy	+61,946	New	+$843K	0.08%	242

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Granite Investment Partners's OXFD Position: Q4 2019 in Review

Granite Investment Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2019, closing a stake of 36,265 shares — an estimated $603K sold.

Granite Investment Partners first reported a position in OXFD in Q1 2015 and held it in 7 quarters. The position peaked at $1.35M in Q3 2015. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

Granite Investment Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2019 after selling out during the quarter.
Granite Investment Partners sold 36,265 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $603K.
Granite Investment Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 7 quarters.
Granite Investment Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.35M in Q3 2015.
68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on Granite Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.